e*

Chapter Seven

e

e-f.eI?.a

irei!Sfwa

7. REFERENCES

Abdou, H.M. (1989). Theory of dissolution. In: Gennaro, A., Migdalof, B., Hassert, G.I.,

Medwick, T. (Eds.), Dissolution, bioavailability and bioequivalence, Mack

publishing, Pennsylvania, pp. 11-36.

Ain, Q., Shamia, S. and Khullar, O.K. (2003). Chemotherapeutic potential o f orally

administered poly (DL-lactide-co-glycolide) microparticles containing isoniazid,

rifampicin and pyrazinaniide against experimental tuberculosis. Antimicrob.

Agents Chemother., 47, 3005-3007.

Ain, Q., Sharma, S., Garg, S.K., and Khullar, G.K. (2003). Roll of Poly (DL-lactide-co-

glycolide) in development of a sustained oral drug delivery system for

antitubercular drug(s). Int. J. Pharm., 239, 37-46.

Al-Musa, S., Fara, D.A., Badwan, A.A. (1999). Evaluation of parameters involved in

preparation and release of drug loaded in cross-linked matrices of alginate. J.

Control. Release, 57 (3), 223-232.

Ammouiy, N., Fessi, H., Devissaguet, J.P., Dubrasquet, M. and Benita, S, (1991). Jejuna

absorption, pharmacological activity and pharaiacokinetic evaluation o f poly (d,l-

lactide) and poly (isobutylcyanoacrylate) nanocapsules in rats. Phami. Res., 8,

101-105.

Anderson, J.W., Allgood, L.D., Lawrence, A., Altringer, L.A„ Jerdack, G.R., Hengehold,

D.A. (2000b). Cholesterol-lowering effects of psyllium intake adjunctive to diet

therapy in men and women with hypercholesterolemia: meta-analysis o f 8

controlled trials. Am. I Clin. Nutr., 71,472-479.

Anderson, J.W., Allgood, L.D., Turner, J., Oeltgen, P.R., Daggy, B.P. (1999). Effects of

psyllium on glucose and semm lipid responses in men with type-2 diabetes and

hypercholesterolemia. Am. J. Clin, Nutr., 7 0 ,466-473.

Anderson, J.W., Davidson, M.H., Blonde, L., Brown, W.V., Howard, W.J., Ginsberg, H.,

Allgood, L.D., Weingand, K.W. (2000a). Long term cholesterol-lowering effects

Chapter 7 ____ ____________________________________________ References

Jamia Hamdard 226

of psyllium as an adj unct to diet therapy in the treatment o f hypercholesterolemia.

Am. J. Clin. Nutr., 71,1433-1438.

Anderson, J.W., O ’Neal, D.S., Riddell-Mason, S., Floore, T.L., Dillon, D.W., Oeltgen, P.R.

(1995). Postprandial serum glucose, insulin, and lipoprotein responses to high-

and low-fiber diets. Metabolism, 44, 848-854.

Babu, V.B.M., Khar, R.K. (1990). In vitro and In vivo studies o f sustained release floating

dosage forms containing salbutamol sulphate, Pharmazie, 45, 268-270.

Baker, B.W., Lonsdale, H.K, (1987). Controlled release of biological active agents. Wiley,

New York, pp. 15-71.

Banfi, E,, Scialino, G., Monti-Bragadin, C, (2003). Development of microdilution method to

evaluate Mycobaterium tuberculosis drug susceptibility. J. Antimicrob.

Chemother., 52, 796-800.

Blumenthal, M., Goldberg, A., Brinkmann, J. (2000). Herbal Medicine, Expanded

Commission E Monographs CD-Rom. American Botanical Council, Integrativ

Medicine, Austin, TX.

Bouchoucha, M., Faye, A,, Savarieau, B,, Arsac, M. (2004). Effect of an oral bulking agent

and a rectal laxative administered alone or in combination for the treatment o f

constipation. Gastroenterol. Clin. Biol., 28,438-443.

Bums, S.J., Attwood, D., Barnwell, S.G. (1998). Assessment o f a dissolution vessel designed

for use with floating and erodible dosage forms. Int, J. Pharm,, 160,213-218.

Central tuberculosis division (CTD), (1997).Revised National TB Control Programme.

Technical guidelines for TB Control. Central TB Division Directorate General o f

Health Services Ministry of Health and Family Welfare, New Delhi, pp 37-39

Centres for Disease Control. (1994). Tuberculosis care guide: Highlights from core

curriculum on tuberculosis. Department of Health and Human Services, Division of

Tuberculosis Elimination, Atlanta, Georgia, USA, pp. 639-1819.

Chapter 7 .........

Jamia Hamdard 227

Chang, R.K., Peng, Y., Shukla, A.J, (2005), Pharmaceutical Excipients. Edited by: Raymond

C. Rowe, Paul J. Sheskey and Sian C, Owen, pp, 1470-1488.

Chen, J.L. and Cyr, G.N. (1970). In: R.S. Manly (Ed.), Adhesion in biological systems,

Academic Press, New York, pp. 163-181.

Chickering, D.E., Jacob, J.S., Mathowitz, E. (1995). Bioadhesive microspheres II:

Characterisation and evaluation of bioadhesion involving hard, bioerodible

polymers and soft tissue. React. Polyra., 25,189-206.

Chitnis, V,, Malshe, V.S., Lalla, J.K. (1991). Bioadhesive polymers synthesis, evaluation and

application in controlled release tablets. Drug. Dev. Ind. Pharm., 17, 879-892.

Chiu, H.C., Hsiue, G.H., Lee, Y.P., Huang, L.W. (1999). Synthesis and characterization of

pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system.

J. Biomater. Sci. Polym. Ed., 10, 591-608.

Ch'ng, H.S., Park, H., Kelly, P, and Robinson, J.R. (1985). Bioadhesive polymers as

platforms for oral controlled drug delivery II: Synthesis and evaluation o f some

swelling, water-insoluble bioadhesive polymers. J. Pharni. Sci., 74 (4), 399-405.

Chourasia, M.K., Jain, S.K. (2003). Pharmaceutical approaches to colon targeted drug

delivery systems. J. Pharm, Pharm. Sci., 6, 33-66,

Chourasia, M.K., Jain, S.K. (2004). Polysaccharides for colon targeted drug delivery. Drug

Deliv,, 11, 129-148.

Chowdary, K.P.R, Srinivas, L, (2000). Mucoadhesive Drug delivery systems: A review of

current status. Indian Drugs, 27(9), 400-406.

Costa, P. and Lobo, J.M.S. (2001). Modelling and comparison of dissolution profile. Eur. J.

Pharm,, 13,123-133.

Couveur, P,, Lnarts, V., Kante, B,, Roland, M. and Speiser, P. (1980). Oral and parenteral

administration of insulin associated to hydrolysable nanoparticles. Acta. Pharm.

Technol., 26, 220-222.

_____________ _________________ References

Jamia Hamdard 22d

Cui, Fu-de., Yang, Ming-shi., Jiang, Yanyan,, Cun, Dongmei., Lin, Wenliui., Fan, Yuling.,

Kawashima, Yoshialci. (2003). Design o f sustained-release nitrendipine

microspheres having solid dispersion structure by quasi-emulsion solvent

diffLision method. J. Control. Release, 91, 375-384.

Currie, A.J., and Tervey, J.R. (1982). An enzymic method for the assay of D- Mannuronan-

C5- epimerase activity. Carbohydrate Res., 107(1), 165-169.

Dahl, TC. (2005). Pharmaceutical Excipients. Edited by: Raymond C. Rowe, Paul J. Sheskey

and Sian C. Owen. 737-753.

Danige, C., Defontaine, M., Aprahamian, M., Michael, C., Humbert, W. and Devissaguet, J.P.

(1991). Preferential uptake of nanocapsules through Payer’s patches in the rat.

Proceed, of the is"’ Symp. Control. Release Bioact. Mater., Amsterdam, pp. 349-

350.

Das, A.R., Dattagupta, N., Sridhar, C.N., and Wu, W.K. (2003). A novel thiocationic

liposomal formulation of antinsense oligonucleotides with activity against

Mycobacterium tuberculosis, Scand. J. Infect. Dis., 35, 168-174.

Derjaguin, B.V. and Smiiga, V.P.( 1966). In: Adhesion: Fundamentals and practice

proceedings, The Ministry of Technology, Gordon and Breach Science Publishers,

Univ. of Nottingham, pp. 152.

Derjaguin, B.V., Toporov, Y.P., Muller, V.M. and Aleinikova, LN. (1977). On the

relationship between the electrostatic and molecular component o f the adhesion of

elastic particles to a solid surface, J. Colloid Interface Sci., 58, 528-533.

Devissaguet, J.P., Fessi, H., Ammoury, N. and Barratt, G. (1992). Colloidal drug delivery

systems for gastrointestinal application. In: Drug targeting and delivery (Concepts

in dosage fonn deign), Junginger, H.E. (Eds.), Ellis H aw ood Ltd., West Sussex,

England, pp 71-91.

Dubey, R.R., Parikh, R.H. (2004). Two stage optimization process for formulation of chitosan

microspheres. AAPS PharmSciTech, 5 (1) Article 5

(http://www,aapspharmscitech.org).

Chapter 7 References

aJamia Hamdard 229

Duchene, D., Toucliard, E. and Peppas, N.A. (1988). Pharmaceutical and medicinal systems

for drug administration. Dmg Dev. Ind. Pliarm., 14, 283-318.

Dutt, M., and Khullar, G.K. (2000). Liposomes and poly (DL-iactide-co-glycolide)

microparticles as sustained release antitubercular drug carriers- an in vitro and in

vivo study. Int. J. Antimicrob. Agents, 18, 245-252,

Dutt, M., and Khullar, G.K. (2000). Poly (DL-lactide-co-glycolide) microparticles as carriers

for antimycobacterial drug rifampicin. Ind. J. Exp. Biol, 38, 887-894.

Dutt, M., and Khullar, G.K. (2001). Chemotherapy o f Mycobacterium tuberculosis infection

in mice with a combination of isoniazid and rifampicin entrapment in poly (DL-

lactide-co-glycolide) microparticles. J. Antimicrob. Chemother., 47, 829-835.

Dutta, S., Karki, R., Shivananda, P. G., Udupa, N. (2000). Liposome encapsulated rifampicin

and isoniazid. Ind. J. Pharm. Sci., 62 (5), 384-387.

Eldridge, J.H., Hammond, C.J., Meulbroke, J.A., Staas, J.K., Gilley, R.M. and Tice, T.R.

(1990). Controlled vaccine release in the gut associated lymphoid tissue I. orally

administered biodegradable microspheres target the Payer’s patches. J. Control.

Release, 11,205-214.

EI-Hag Ali Said, A. (2005). Radiation synthesis of interpolymer polyelectrolyte complex and

its application as a carrier for colon-specific drug delivery system. Biomaterials,

26, 2733-2739.

El-Kamel, A.H., Sokar, M,S.,A1 Gamal, S.S., Naggar, V.F. (2001). Preparation and evaluation

of ketoprofen floating oral delivery system. Int. J. Pharm., 220, 13-21.

Fagerberg, S.E. (1982). The effects of a bulk laxative (Metamucil) on fasting blood glucose,

serum lipids and other variables in constipated patients with non-insulin

dependent adult diabetes. Curr. Ther. Res., 31,166-172.

Fasano, A. (1998). Novel approaches for oral delivery of macromolecules. J.Pharm. Sci,, 87,

329-334.

Chapter 7 _ _________ __ ________________________References

Jamia Hamdard 230

Chapter 7 ____________ References

Fattah, E.A.E., Grant, D.J.W., Gabr, K.E., Meshali, M.M, (1998). Physical characteristics and

release behavior of salbutamol sulfate beads prepared with different ionic

polysaccharides. Drag Dev, Ind. Pharm., 24 (6) 541-547.

Fernandez-Banares, F., Hinojosa, J., Sanchez-Lombrana, J.L., Navarro, E., Martinez-

Salmeron, ,f.F., Garcia-Puges, A., Gonzalez-Huix, F., Riera, J,, Gonzalez-Lara, V.,

Domiiiguez-Abascal, F,, Gine, J.J., Moles, J., Gomollon, F,, Gassull, M.A. (1999).

Randomized clinical trial of Plantago ovate seeds (dietary fiber) as compared

with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for

the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU), Am. J.

Gastroenterol., 94, 427-433.

Fischer, H.M., Nanxiong, Y., Ralph, R.G.J., Andersond, L., Marietta, J.A. (2004). The gel-

forming polysaccharide of psyllium husk {Plantago ovata Forsk). Carbohydrate

Res., 339, 2009-2017.

Florholmen, J., Arvidsson-Lenner, R., Jorde, R., Burhol, P.G. (1982). The effect o f

Metamucil on postprandial blood glucose and plasma gastric inhibitory peptide in

insulin-dependent diabetics. Acta Med. Scand., 212, 237-239.

Fourie, B., Pillai, G. C,, Melleron, H., Sinith, P., Panchangnula, R., Ellard, G., Spinaci, S.,

Blomberg, B. (1999). Establishing the bioequivalence of rifampicin in fixed dose

combination containing isoniazid with/or without pyrazinaraide and/or ethambutol

compared to the single drug reference preparations administered in loose

combination: model protocol. WHO/CDS/TB/99., WHO, Geneva, 274.

Fukagawa, N.K., Anderson, J.W., Hageman, G., Young, V.R., Minaker, K.L. (1990). High-

carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy

young and old adults. Am, J. Clin. Nutr., 52, 524-528.

Gabor, F., Wirth, M., Jurkovich, B., Haberl, I., Theyer, G., Walcher, G., Hamilton, G. (1997).

Lectin mediated bioadhesion: proteolytic stability and binding characteristics o f

wheat germ agglutinin and Solamm tuberosum lectin on Caco-2, HT-29 and

human colonocytes. J. Control. Release, 49, 27-37.

Jamia Hamdard 231

Gansbeke, B.V., Timmermans, J., Schoutens, A., Moes, A i. (1991), Intragastric positioning

o f tw o concuiTentiy ingested pharmaceutical m atrix dosage forms. Nucl. Med.

Biol., 18,711-718.

Gaserod, 0., Jolliffe, I.G., Hampson, F.C., Dettmar, P.W., Skjak-Braek, G. (1998). The

enhancement of the bioadhesive properties of calcium alginate beads by coating

with chitosan. Int. J. Pharm., 175 (2), 237-246.

Gasper, M.M., Neves, S., Portaels, F., Pedrosa, J., Silva, M.T., and Cruz, M.E. (2000).

Therapeutic efficacy of liposomal rifabutine in a Mycobacterial avium model o f

infection. Antimicrob. Agents Chemother., 44, 2424-2430,

Gombotz, W.R., Wee, S.F. (1998), Protein release from alginate matrices. Adv. Drug Deliv.

Rev., 31 (1-2) 267-285.

Good, R,J. (1977). Surface free energy of solids and liquids; themiodynamics, molecular

forces, and structures. J. Colloid Interface Sci., 59, 398-419.

Goyal, P., Pandey, S., Udupa, N, (2002). Simultaneous spectrophotoraetric estimation o f

isoniazid and rifampicin from combined dosage forms. Ind. J. Pharm. Sci,, 76-78.

Gu, J.M., Robinson, J.R., Leung, S.H.S. (1988). Binding of acrylic polymers to

mucin/epithelial surfaces: Structure-property relationships. Crit. Rev. Therap,

Drug Carrier Syst., 5(1), 21-67.

Guo, Qian., Steve, W., Cui, Q,, Wang, J., Christopher, Young. (2008). Fractionation and

physicochemical characterization of psyllium gum. Carbohydrate Polymers, 73,

35-43.

Gupta, K.C., Jabrail, F.H. (2007). Gluteraldehyde cross-linked chitosan microspheres for

controlled release of centchroman. Carbohydrate Res., 342, 2244-2252,

Gupta, R.R,, Argawal, C.G., Singh, G.P., Ghatak, A. (1994). Lipid-lowering efficacy of

psyllium hydrophilic mucilloid in non insulin dependent diabetes mellitus with

hypercholesterolemia. Indian J. Med. Res., 100, 237-241.

Chapter 7_________________________________________________________ References

Jamia Hamdard 232

Haas, J., Lehr, C.M, (2002). Developments in the area of bioadhesive drag delivery systems.

Expert Opin, Biol. Ther., 2, 287-298.

Haltner, E., Easson, Lehr, C.M. (1997). Lectins and bacterial invasion factors for

controlling endo and transcytosis of bioadhesive drug carrier systems. Eur. J.

Pharm. Biopharm., 44, 3-13.

Helfand, E. and Tagami, Y. (1972a). Theoiy of interface between immiscible polymers. J,

Chem. Phys.,57, 1812-1813.

Helfand, E. and Tagami, Y. (1972b). Theory of the interface between immiscible polymers.

II. J. Chem. Phys., 56, 3592-3601.

Higuchi, T, (1963). Mechanism of sustained action medication, theoretical analysis o f rate o f

release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 52, 1145-1149.

Hixson, A.W., Crowell, J.H. (1993). Dependence of reaction velocity upon surface and

agitation (1) theoretical consideration. Ind. Eng. Chem., 23, 923-931.

Holmes, A. and Gamer, P. (1999). Tuberculosis. Clin. Evid. 1, 1-7,

Horowitz, M.L and Pigman, W. (1977). The Glycoconjugates, Vol. 1, Academic Press, New

York, 423-440.

Hosny, E.A., Al-Helw, A.A.M. (1998). Effect of coating o f aluminum

carboxymethylcellulose beads on the release and bioavailability of diclofenac

sodium. Pharm. Acta Helv., 72 (5) 255-261.

Huntsberger, J.R. (1967). Mechanism of adhesion. J. Paint Technol., 39,199-211.

Huntsberger, J.R. (1966), In; R.L. Patrick (Eds.), Treatise on adhesion and adhesives, Vol. 1,

Marcel Dekker, New York, pp. 119-150.

Ikeda, K,, Murata, K., Kobayashi, M., Noda, K. (1992). Enhancement o f bioavailability of

dopamine v/a nasal route in beagle dogs. Chem.Pharm. Bull., 40, 2155-2158.

Chapt^T^^ ^ ___________________________________________________________________ ______________________ References

Jamia Hamdard 233

Indian Pharmacopoeia, (2007a). Published by the Indian Pharmacopoeia Commission,

Ministry of Health and Family Welfare, Govt, o f India, Ghaziabad, Vol. 2,

pp. 1247-1248.

Indian Pharmacopoeia. (2007b), Published by the Indian Pharmacopoeia Commission,

Ministiy of Health and Family Welfare, Govt, o f India, Ghaziabad, Vol. 2, p. 24.

Indian Pharmacopoeia. (2007c). Published by the Indian Pharmacopoeia Commission,

Ministry of Health and Family Welfare, Govt, o f India, Ghaziabad, Vol. 2,

pp. 1659-1660.

Indian Pharmacopoeia. (2007d). Published by the Indian Pharmacopoeia Commission,

Ministry of Health and Family Welfare, Govt, of India, Ghaziabad, Vol. 2, p. 388.

Chapter 7 ......................

International Union Against Tuberculosis and Lung Disease (lUATLD). (2000). Management

of tuberculosis: a guide for low income countries. ed. 68 boulevard Saint-

Michel, Paris, France, pp. 1-117

Jacob, J.S., Mathiowitz, E, (2000). US Pat. No. 6,123,965.

Jain, C.P,, and Vyas, S.P., (1995). Preparation and characterization o f niosomes containing

rifampicin for lung targeting. J. Microencapsul., 12,401-407.

Jain, S. K., Awasthi, A. M., Jain, N. K,, Agrawal, G. P. (2005). Calcium silicate based

microspheres of repaglinide for gasti'oretentive floating drug delivery; Preparation

and in vitro characterization. J, Control. Release, 107, 300- 309.

Jindal, K.C., Chaudhary, R,S,, Singla, A,K., Gangwal, S.S,, Khanna, S. (1994). Dissolution

test method for rifampicin-isoniazid fixed dose formulations. J. Pharm. Biomed.

Anal, 12(4), 493-497.

Joseph, N.J., Lakshmi, S., Jayakrishnan, A. (2002). A floating-type oral dosage form for

piroxicam based on hollow polycai’bonate microspheres: in vitro and in vivo

evaluation in rabbits. J. Control. Release, 79, 71-79.

Kaelble, D.H. (1974). A relationship between the fracture mechanics and surface energy

failure criteria. J, Appl. Polym. Sci. 18,1869.

Jamia Hamdard 234

Kamatli, M.P„ Shenoy, B.D., Tiwari, S,B., Karki, R., and Udupa, N. (2000). Prolonged

release biodegradable vesicular earners for rifampicin formulation and kinetics of

release, Ind. J. Exp. Biol., 38, 113-118.

Kamath, R., Kalpana, Park, Kinain. (1995). Mucosal Adhesive preparations. In: Encyclopedia

of Pharmaceutical Technology. Mercel & Dekker, 12, pp. 132-162.

Kainmer, H.W. (1983). Adhesion between polymers-Review, Acta Polymerica, 34: 112-118.

Karajgi, J., Jain, N.K., Vyas, S.P. (1993). Passive vectoring of a colloidal carrier system for

sodium stibogluconate, preparation, charecterization and performance evaluation.

J. Drug Target., 1, 197-206.

Katchalsky, A., Cooper, R.E., Upadhyay, J., Wassermann, A. (1961). Counter-ion fixation in

alginates. J. Chera. Soc., 12, 5198-5204.

Kennedy, J.F., Sandhu, J.S., Southgate, D.A.T. (1979). Structural data for the carbohydrate of

ispaghula husk ex Plantago ovata Forsk. Carbohydrate Res., 75, 265”274.

Khotimchenko, Y.S., Kovalev, V.V., Savchenko, O.V., Ziganshina,O.A. (2001). Physical-

chemical properties, physiological activity, and usage of alginates, the

polysaccharides of brown algae. Russian Journal o f Marine Phamacology, 27,

S53-S63.

Kibbe, A.H, (2005). Pharmaceutical Excipients. Edited by: Raymond C. Rowe, Paul J.

Sheskey and Sian C. Owen, pp, 2033-2040.

Kinloch, A.J. (1980). The science of adhesion: I. Surface and interfacial aspects. J. Mater.

Sci., 15,2141-2166.

Kriwet, B., Kissel, T. (1996). Interactions between bioadhesive poly (aciylic acid) and

calcium ions. Int. J. Phami., 127, 135-145.

Labana, S., Pandey, R., Sharma, S., Kliullar, G.K. (2002), Chemotherapeutic activity against

murine tuberculosis of once weekly administered drags (isoriiazid and rifampicin)

encapsulated in liposomes. Int. J. Antimicrob. Agents, 20, 301-304.

Chapter 7 ________________________ _________ ^ ___________________________

Jamia Hamdard 235

Labat-Robert, J, and Decaeus, C. (1979). Gastric mucus glycoproteins: Structure, functions

and pathology. Pathol. Biol. (Paris), 27(4), 241-247.

Laidlaw, R.A., Purcival, E.G.V. (1950). Studies of seed mucilages. Part V. Examination o f a

polysaccharide extracted from the seeds of Plantago ovata Forsk by hot water. J.

Chem. Soc„ 528-534.

Lee, J. H., Park, T. 0 ., Choi, H, K. (1999). Development of oral drug delivery system using

floating microspheres. J. MicroencapsuL, 16, 715- 729.

Lee, J.W., Park, J.H., Robinson, J.R. (2000), Bioadhesive based dosage forms: the next

generation, J, Pharm, Sci., 89, 850-866.

Lehr, C,M., Bouwstra, J.A., Kok, W., Noach, deBoer, A.G., Junginger, H.E. (1992).

Bioadhesion by means of specific binding of tomato lectin. Pharm. Res., 9, 547-

553.

Lehr, C.M., Bowstra, J.A., Tukker, J.J., Junginer, H.F, (1990), Intestinal transit time of

bioadhesive microspheres in an in situ loop in the rat. J. Control, Release, 13, 51-

61.

Lele, B.S,, Hofftnan, A.S. (2000). Mucoadhesive drug carriers based on complexes of

poly (aery lie acid) and PEGylated drugs having hydrolysable PEG-anhydride-

drug linkages. J. Control. Release, 69,237-248.

Lenearts, V. and Gurny, R. (1990). Bioadhesive Drug Delivery Systems. CRC Press, Boca

Raton, FL, pp. 93-104.

Li, S„ Lin, S., Daggy, B.F., Mirchandani, H.L., Chien, T.W. (2002). Effect o f fonnulation

variables on the floating properties of gastric floating drug delivery system. Drug.

Dev. Ind. Pharm,, 28, 783-793.

Liu, X,D„ Bao, D.C., Xue, W.M., Xiong, Y., Yu, W.T., Yu, X.J., Ma, X.J., Yuan, Q. (2002a).

Preparation of uniform calcium alginate gel beads by membrane emulsification

coupled with internal gelation. J. Appl. Pol. Sci., 87, 848-852.

C h a ^ i ^ __ _____________________ ____________________________________References

Jamia Hamdard 236

Liu, X.D., Yu, W.Y., Zhang, Y„ Xiie, W.M., Yu, W.T., Xiong, Y„ Ma, X J., Chen, Y., Yuan,

Q. (2002b). Characterization of structure and diffusion behaviour of Ca-alginate

beads prepared with external or internal calcium sources. J. MicroencapsuL, 19,

775-782.

Long, M.W., Snider, D.R., Farer, L.S, (1979). US Public health service cooperative trial o f

three rifampicin-isoniazid regimens in the treatment of pulmonary tuberculosis.

Am. Rev, Respire. Dis., 119, 879-894,

Lopes, E,, Pohlniann, A.R., Bassani, V. and Gurteress, S.S. (2000). Polymeric colloidal

system containing ethionamide: preparation and physiochemical characterization.

Pharmazie, 55, 527-530.

Lordi, G and Reichman, L (1999). Tuberculosis. Cuit. Pract. Med., 2, 621-626.

Lucinda-Silva, R.M., and Evangelista, R.C. (2003). Microspheres o f alginate-chitosan

containg isoniazid, J. Microencapsui,, 20, 145-152.

Maincent, P., Le Verge, R., Sado, P., Couveur, P. and Devissaguet, J.P, (1986). Disposition

kinetics and oral bioavailability of vincamin-loaded polycyanoacrylate

nanoparticles. J. Phann. Sci., 75, 955-958.

Malmstern, M. (2002). Polymer particles. In: Surfactants and polymers in drug delivery.

Marcel Dekker, New York, pp. 271 -290.

Mariappan, T.T., Geetha, Thiraviam., Pandey, Rajesh., Jindal, K.C., Singh, Saranjit, (2004).

Interference of isonicotinyl hydrazone in the microbiological analysis of

rifampicin from anti-tuberculosis FDC products containing isoniazid. J. Phann.

Biomed. Anal, 36, 643-647.

Martin, A. (1991). Physical Pharmacy. Lea Febiger, Philadelphia, IV '' ed., pp. 423- 451.

Maurizio, R., Giovagnoli, S., Blasi, P., Schoubben, A., Perioli, L., Rossi, C. (2006).

Development of liposomal capreomycine sulphate formulation: Effect of

formulation variables on peptide encapsulation. Int. J. Pharm., 311, 172-188.

Chapter? ^ ^ ____________________ ______ ^ _________________________ R e fe re n ts^

Jamia Hamdard 237

Mikos, A.G. and Peppas, N.A. (1986). Systems for controlled-release of drugs. V.

Bioadhesive systems. S.T.P. Phanna., 2, 705-716,

Mirghani, A., Idkaidek, N.M., Salem, M.S., Najib, N.M. (2000). Formulation and release

behavior of diclofenac sodium in compritol 888 matrix beads encapsulated in

alginate. Drug Dev. Ind. Pharm., 26 (7), 791-795,

Mislira, B., .fayanth, P. and Sankar, C. (2003). Development of chitosan-alginate

microcapsules for colon speci fic delivery of metronidazole. Indian Drugs, 40 (12),

695-700.

Mojaverian, P.,VIasses, P.M., Kellner, P.E.,Rocci Jr., M.L. (1988). Effects of gender, posture,

and age on gastric residence time of an indigestible solid: Phantiaceutical

considerations. Pharm. Res., 10, 639-644.

Moreyra, A.E., Wilson, A.C., Koraym, A, (2005), Effect o f combining psyllium fiber with

simvastatin in lowering cholesterol. Arch. Int, Med, 165,1161-1166.

Mulye, N.V. and Turco, S.J. (1995), A simple model based on first order kinetics to explain

release of highly water soluble drugs from porous dicalcium phosphate dihydrate

matrices. Drug Dev. Ind. Pharm., 21, 943-953.

Oliver, S.D. (2000). The long-term safety and tolerability of ispaghula husk. J. R. Soc. Health,

120, 107-111.

0th, M., Franz, M., Timmermans, J., Moes, A.J. (1992). The bilayer floating capsule: A

stomach-directed drug delivery system for misoprostol. Pharm. Res., 9, 298-302.

Pandey, R. and Khullar, G.K. (2004a). Chemotherapeutic potential o f alginate-chitosan

microspheres as anti-tubercular drug carriers. J. Antimicrob. Chemother., 53, 635-

640.

Pandey, R. and Khullar, G.K. (2004b). Subcutaneous nanoparticle-based antitubercular

chemotherapy in an experimental model. J. Antimicrob, Chemother., 54(1):266-

268.

7 _______ References

Jamia Hamdard 238

Pandey, R., Sharma, S., Zahoor, A., Khullar, G.K. (2003b). Nanoparticles encapsulated

antitiibercular drags as a potential oral drug delivery system against murine

tuberculosis. Tuberculosis (Edinb.), 83, 373-378.

Pandey, R,, Sharma, S., Zahoor, A., Sharma, A., Kliullar, G.K. and Prasad, B. (2Q03a). Poly

(DL-lactide-co-glycolide) nanopaiticles based inhalable sustained drug delivery

system for experimental tuberculosis. J. Antimicrob. Chemother., 52, 981-986.

Park, H, and Robinson, J.R. (1985). Physico-chemical properties of water insoluble polymers

important to mucin/epithelial adhesion. J. Control. Release, 2, 47-57.

Pass!, W.J. (1989). Synthetic polymers in modern pharmacy. Prog. Polym. Sci., 14 (5), 629-

677,

Pastors, J.G., Blaisdell, P.W., Balm, T.K., Asplin, C.M., Pohl, S.L, (1991). Psyllium fiber

reduces rise in postprandial glucose and insulin concentrations in patients with

non-insulin-dependent diabetes. Am. J. Clin. Nutr., 53, 1431-1435.

Patel, J.K., Patel, R.P., Amin, A.F., Patel, M.M. (2005). Fonnulation and evaluation of

mucoadhesive glipizide microspheres. AAPS PharmSciTech, 6: E49-55.

Peppas, N.A, and Buri, P.A. (1985). Surface, interfacial and molecular aspects of polymer

bioadhesion on soft tissues. J. Control. Release, 2, 257-275.

Pigman, W. and Gottschalk, A.(1966). In: A, Gottschalk (Eds.), Glycoproteins: Their

Composition, Structure and Function, Vol. 5, Elsevier, Amsterdam, pp. 434-445.

Pittler, M.FI., Ernst, E. (2004). Dietary supplements for body-weight reduction: a systematic

review. Am. J. Clin. Nutr., 79, 529-536.

Poncelet, D., Babak, V., DuHeu, C,, Picot A. (1999). A physico-chemical approach to

production of alginate beads by emulsification-intemal ionotropic gelation.

Colloids and Surfaces A: Pliysiochemical and Engineering Aspects, 155, 171-

176.

Chapter 7_ ___ References

Jamia Hamdard 239

Poncelet, D,, Lencki, R„ Beaulieu, C., Halle, J,P., Neufeld, R.J., Fournier, A. (1992).

Production of alginate beads by emulsification/internal gelation. I. Methodology.

Applied Microbiology & Biotechnology, 38, 39-45.

Ponchel, G, and Duchene, D. (1991), In: M, Szycher (Eds.), High Performance Biomaterials,

Technomic, Lancaster, PA, pp. 231 -242.

Ponchel, G., Touchard, F., Duchene, D., Pappas, N.A. (1987). Bioadhesion analysiws of

controlled-release systems. I. Fracture and interpenetration analysis in

poiy(acryIic acid)-containing systems, J. Control. Release, 5, 129--141.

Quenelle, D.C., Winchester, G.A., Staas, J.K., Barrow, E.L.W. and Barrow, W.W. (1999).

Efficacy of microencapsulated rifampicin in Mycobacterium tuberculosis-infected

mice. Antimicrob. Agents Chemother., 43, 1144-1151.

Quenelle, D.C., Winchester, G.A., Staas, J.K., Barrow, E.L.W. and Baixow, W.W. (2001).

Treatment of tuberculosis using a combination of sustained-release rifampicin-

loaded microspheres and oral dosing with isoniazid. Antimicrob. Agents

Chemother., 45,1637-1644.

Rajinikanth, F.S., Sankar, C., Mishra, B. (2003). Sodium alginate microspheres o f metoprolol

tartarate for iiitranasal systemic delivery; development and evaluation. Drug D el,

10,21-28,

Ramkumar, D., Rao, S.S, (2005). Efficacy and safety of traditional medical therapies for

chronic constipation: systematic review. Am. J, Gastroenterol, 100, 936-971.

Ranga Rao, K.V. Buri, P. (1988), Bioadhesion and factors affecting the bioadhesion of

microparticles. In: M. Szycher (Eds.), High Performance Biomaterials, Lancaster

PA, Technomic Publishing Company, New York, pp. 259-268

Raviglione, M, and O’Brien, R. (1998). Tuberculosis. In: Harrison’s principles o f internal

medicine, Fauci, A,S„ Braunwald, E., Isselbacher, K. J, (Eds.), Me Graw Hill,

New York, 1004-1014.

Chapter 7 ____ References

Jamia Hamdard 240

Chapter 7 _________________ References

Rodriguez-Moraa, M., Guerrero-Romero, F., Lazcano-Burciaga, G. (1998). Lipid and

glucose-lowering efficacy of Plantago psyllium in type II diabetes. J, Diabetes

Compiicat. 12, 273-278,

Romero, A.L., West, K.L., Zern, T., Fernandez, M.L, (2002). The seeds from Plantago ovata

lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs. J.

Nutr,, 132,1194-1198.

Rouge, N., Aliemann, E., Gex-Fabry, M. (1997). Comparative phannacokinetic study o f a

floating multiple unit capsule, a high density multiple unit capsule and an

immediate release tablet containing 25mg atenolol. Pharm. Acta. Helv., 73, 81-87.

Rouge, N., Leroux, J.C., Cole, E.T., Doelker, E., Buri, P. (1997). Prevention of the sticking

tendency of floating minitablets filled into hard gelatin capsules. Eur. J. Pharm.

Biophami,, 43,165-171.

Sandhu, J.S., Hudson, G.J., Kennedy, J.F. (1981). The gel nature and stmcture o f the

carbohydrate of ispaghula husk ex Plantago ovata Forsk. Carbohydrate Res., 93,

247-259.

Santos, C.A,, Jacob, J.S., Hertzog, B.A., Carino, G.F., Mathiowitz, E. (2000). US Pat. No.

6,156,348.

Sato, Y., Kawashima, Y., Takeuchi, H., Yamamoto, H. (2003). Physicochemical properties to

detennine the buoyancy of hollow microspheres (microballons) prepared by the

emulsion solvent diffusion method, Eur. J. Phami. Biopharm., 55,297-304.

Scawen, M, and Allen, A, (1977). The action o f proteolytic enzymes on the glycoprotein from

pig gastric mucus. J. Biochem., 163(2) 363-368,

Sethuraman, V.V,, and Hickey, A.J. (2002). Powder properties and their influence on dry

powder inhaler delivery of an antitubercular drug. AAPS PharmSciTech, 3, 28-34.

Sharma, R., Saxena, D., Dwivedi, A.K. and Misra, A. (2001), Inhalable microsphere

containing drug combinations to target alveolar macrophages for treatment of

pulmonary tuberculosis. Pharm. Res., 18, 1405-1410.

—Jamia Hamdard 241

Shilpa, A., Agrawai, S. S., Ray, A. R. (2003), Controlled delivery o f drugs from alginate

matrix. J. Macromolecular Science part C-Polymer Reviews. 43 (2) 187-221.

Shi'shoo, C.J., Shah, S.A., Rathod, I.S., Salve, S.S., Vora, M.J. (2001). Impaired

bioavailability of rifampicin in presence of isoniazid from fixed dose combination

(FDC) formulation. Int. J. Pharm., 228, 53-67.

Singh, B,, Chauhan, G.S., Bhatt, S.S., Kumar, K. (2006). Metal ion sorption and swelling

studies of psyllium and acrylic acid based hydrogels. Carbohydrate Polym., 64,

50-56.

Singh, B.M., Kim, K,H. (2000). Floating dmg deliveiy systems: an approach to oral

controlled drug delivery via gastric retention. J. Control. Release, 63 (1-2), 235-

259.

Singh, S., and Mohan, B. (2003). A pilot stability study on four fixed-dose combination ajiti-

tuberculosis products. Int. J. Tuberc. Lung Dis., 7, 298-303.

Singh, S., Bhutani, H., Mariappan, T.T., Kaur, H., Bajaj, M., Pakhale, S.P. (2002). Behaviour

of uptake of moisture by drugs and excepients under accelerated conditions o f

temperature and humidity in the absence and presence o f light. 1. Pure anti­

tuberculosis drugs and their combinations. Int. J. Pharm. 245, 37-44.

Singh, S., Mariappan, T.T., Sankar, R., Sharda, N, and Singh, B. (2001), A critical revievi o f

the probable reasons for the poor/variable bioavailability o f rifampicin from the

ant-tubercular fixed dose combination (FDC) products, and the likely solutions to

the problem. Int. J. Phami,, 228, 5-17,

Singh, S,, Mariappan, T,T,, Sharda, N., Singh, B. (2000). Degradation of rifampicin, isoniazid

and pyrazinamide from prepared mixtures and marketed single and combination

products under acid conditions. Pharm. Pharmacol. Commun., 6,491-494.

Skidan, I.N., Gel’perina, S.E. and Guliaev, A.E. (2003). Enhanced activity of rifampicin

loaded polybutylcyanoacrylate nanoparticles in relation to intracellularly localized

bacteria. Antibiot. Khimother,, 48, 23-26.

Spiro, R.G,(1970). Glycoproteins. Annual Review of Biochemistry, 39, 599-638.

Chapter 7 References

Jamia Hamdard 242

Suarez, S., O’Hara, P., Kazantseva, M,, Newcomer, C.E., Hopfer, R., Me Murray, D.N. and

Hickey, A.J. (2001). Aiways delivery of rifampicin microparticles for the

treatment of tuberculosis. J. Antimicrob. Chemother., 48, 431-434.

Sultana, Y., Mall, S., Maurya, D. P., Kumar, D., Das, M. (2009), Preparation and in vitro

characterization of diltiazem hydrochloride loaded alginate microspheres. Pharrn.

Dev. Tech., 14(3), 321-331.

Tabor, D. (1977). Surface forces and surface interactions. J. Colloid Interface Sci., 58, 2-13.

Takka, S., Ocak, O.H., Acarturk, F. (1998). Formulation and investigation of nicardipine HCl-

alginate gel beads with factorial design based studies. Ear. J. Pharm. Sci., 6 (3)

241-246.

Talukder, R., Fassihi, R. (2004). Gastroretentive delivery systems: a mini review . Drug. Dev.

Ind. Pharm., 3 0 ,10I9-I028.

ThrolU'H., Freitas, J.E., Swanso, D. (1976). Clinical composition o f cardiac blood pool

visualization with ‘‘’"’Tc HAS. J. Nucl, Med., 19, 796-803.

Timmermans, J., Andre, J.M. (1994), Factors controlling the buoyancy and gastric retention

capabilities of floating matrix capsules: new data for reconsidering the

controversy. J. Phann, Sci., 83,18-24.

Timmermans, J., Gansbeke, V.B., Moes, A.J. (1989). Assessing by gamma scintigraphy the in

vivo buoyancy of dosage forms having known size and floating force profiles as a

function of time. Proceedings of the 5 '’ International Conference on Pharmacy

Technology. Paris, France APGI. 1, pp. 42-51.

Timmermans, J,, Moes, A..1, (1990). How well do floating dosage fonns float. Int. J. Pharm.,

62,207-216.

Tonnesen, H. FI., Karlsen, J. (2002). Alginate in drug delivery systems. Drug Dev. Ind.

Pharm., 28(6), 621-630.

Tsapis, N,, Bennett, D., O’Driscoll, K., Shea, K., Lipp, M.M., Fu, K., Clarke, R.W., Deaver,

D., Yamins, D„ Wright, J., Peloquin, C.A., Weitz, D.A., and Edwards, D.A.

Chapter 7 ___ ^ ______ References

jamia Hamdard 243

(2003). Direct lung delivery of para-aminosalicylic acid by aerosol particles.

Tuberculosis (Edinb.)., 83, 379-385.

Umamaheshwari, R.B., Jain, vS., Bhadra, D„ Jain, N.K. (2003). Floating microspheres bearing

acetohydroxairiic acid for the treatment o f Helicobacter pylori. J. Phanti.

Pharmacol., 55 (12), 1607-1613.

Varelas, C.G., Dixon, D.G and Steiner, C. (1995). Zero order release from biphasic polymer

hydrogels. J. Control. Release, 34, 185-192.

Volkheimer, G. and Schultz, F.H. (1968). The phenomenon of persoiption. Digestion., 1, 213-

218.

Voyutskii, S. S. (1963). Autohesion and adhesion of high polymers-Polymer Reviews, Nark,

FI. F. and Immergut, E, H. (Eds.), Vol. 4, Hiley, New York, pp.74-80.

Vyas, S.P., Kannan, M.E., Jain, S., Mishra, V., aiid Singh, P.(2004). Design o f liposomal

aerosols for improved delivery of rifampicin macrophages. Int. J. Pharm., 269, 37-

49.

Washington, N,, Harris, M., Mussellwhite, A., Spiller, R.C. (1998). Moderation of lactulose-

induced diarrhoea by psyllium: effects on motility and fermentation. Am, J. Clin.

Nutr., 67,317-321.

Whitehead, L., Fell, J,T., Collett, J.H., Sharnia, H.L., Smith, A.M. (1998). Floating dosage

forms: An in vivo study demonstrating prolonged gastric retention. J. Control.

Release, 55, 3-12.

World Health Organization (WHO). (1993). WHO declares tuberculosis a global emergency.

Soz-Praevmed., 38, 25!-252.

World Health Organization (WHO). (2003). Treatment of tuberculosis. Guidelines for

National Programmes. WHO/CDS/TB 2003, 3'' ed., Geneva, Switzerland, WHO,

313.

World Health organization. (1994). TB a global emergency, WHO TB programme. Geneva:

Switzerland.; WHO/TB/94,177:1-28.

Chapter ? References

Jamia Hamdard 244

Yang, L., Fassihi, R. (1996). Zero order release kinetics from self correcting floatable

configuration drug delivery system. J. Pharm. Sci., 85,170-173.

Yang, Ming-shi., Cui, Fu-de,, You, Ben-gang., Fan, Yu-ling,, Wang, Liang., Yue, Peng.,

Yang, He. (2003). Preparation of sustained-release nitrendipine microspheres with

Eudragit RS and Aerosii using quasi-emulsion solvent diffusion method. Int. J.

Pharm., 259,103~-113.

Zaiioor, A., Sharma, S., Khullar, G.K, (2005). Inhalable alginate nanoparticles as

anti tubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob.

Agents, 26 (4), 298-303.

Zhang, W., Jiang, X„ Hu, J., and Fu, C. (2000). Rifampicin polylactic acid microspheres for

lung targeting. J. Microencapsul,, 17, 785-788.

Ziyaur, R., Kanchan, K., Kiiar, R.K., IVfushir, A., Charoo, N.A. (2006). Charad’terization of 5-

fluorouracil microspheres for colonic delivery. AAPS PharmSciTech, 2006; 7 (2)

Article 47 (http://www.aapspharmscitech.org).

Chapter 7 _________ _______________ ____ __ ____________________ References

Jamia Hamdard 245